Angeion announces CEO succession plan

Rodney Young is stepping down as CEO of Angeion and will be replaced by Philip Smith, who comes over from DGIMed. Young will remain with Angeion through Dec. 31, at which time Smith will assume the CEO position. Smith has been a member of Angeion's board for roughly since 2007.

Angeion designs, manufactures and distributes cardiorespiratory diagnostic systems, related software and programs for the management and improvement in individual's overall health and fitness. 

Since 2008, Smith has been president and CEO of DGIMed Ortho, an early-stage medical device company. He also has experience as executive VP, strategy and business development for Vital Images; president and CEO of Thermonix; and vice president, marketing and business development, for Image-Guided Neurologics.

"I am excited and honored to become the CEO of Angeion and to continue working with the company's talented senior management team and employees whom I have had the opportunity to get to know and work with over the past three years," Smith says in a statement. "Rod established a solid, good foundation upon which we can build, and I look forward to continuing to work with the Board to ensure that the company's strategic plan is aligned with marketplace opportunities."

- get the Angeion release

Suggested Articles

A decade-long study found that patients with early breast cancer may be spared radiation procedures that span the whole breast.

A cell therapy for Parkinson’s disease starts out simple, but quickly gets complicated with the potential for immune responses and cancer mutations.

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.